5R01NS097850-07 |
2022 |
$620824 |
Validating Secretory Autophagy as a Therapeutic Strategy for Diverse Forms of ALS and FTD |
5R01NS097850-06 |
2021 |
$623222 |
Validating Secretory Autophagy as a Therapeutic Strategy for Diverse Forms of ALS and FTD |
3R01NS097850-05S1 |
2021 |
$18069 |
Diversity Supplement for Validating Secretory Autophagy as a Therapeutic Strategy for Diverse Forms of ALS and FTD (Butler) |
3R01NS097850-05S2 |
2021 |
$79217 |
Diversity Supplement for Validating Secretory Autophagy as a Therapeutic Strategy for Diverse Forms of ALS and FTD (Santana) |
2R01NS097850-05 |
2020 |
$674414 |
Validating Secretory Autophagy as a Therapeutic Strategy for Diverse Forms of ALS and FTD |
5R01NS097850-04 |
2019 |
$431727 |
The Role of C9ORF72 Protein Function in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia |
5R01NS097850-03 |
2018 |
$596470 |
The Role of C9ORF72 Protein Function in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia |
3R01NS097850-01S1 |
2017 |
$45347 |
The Role of C9ORF72 Protein Function in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia |
3R01NS097850-01S2 |
2017 |
$12908 |
The Role of C9ORF72 Protein Function in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia |
5R01NS097850-02 |
2017 |
$596470 |
The Role of C9ORF72 Protein Function in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia |
1R01NS097850-01 |
2016 |
$412500 |
THE ROLE OF C9ORF72 PROTEIN FUNCTION IN AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA |